As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
14 Analysts have issued a Achieve Life Sciences, Inc. forecast:
14 Analysts have issued a Achieve Life Sciences, Inc. forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -52 -52 |
68%
68%
|
|
| EBIT (Operating Income) EBIT | -52 -52 |
67%
67%
|
|
| Net Profit | -52 -52 |
59%
59%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
| Head office | United States |
| CEO | Richard Stewart |
| Employees | 25 |
| Founded | 1991 |
| Website | achievelifesciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


